MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel

Development of chemoresistance remains a major challenge in treating patients suffering from esophageal squamous cell carcinoma (ESCC), despite treatment advances. MicroRNAs (miRNAs) have been shown to play critical roles in the regulation of ESCC cell chemoresistance. Here, we aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jie, Shi, Litong, Lin, Shan, Li, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806716/
https://www.ncbi.nlm.nih.gov/pubmed/34415232
http://dx.doi.org/10.1080/21655979.2021.1938497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806716/
https://www.ncbi.nlm.nih.gov/pubmed/34415232
http://dx.doi.org/10.1080/21655979.2021.1938497

Ejemplares similares